{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:59:29Z","timestamp":1767977969271,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary enzymatic abnormality that affects more than 400 million people worldwide. Most deficient individuals do not manifest any symptoms; however, several precipitant agents\u2014such as fava intake, infections, or several drugs\u2014may trigger acute haemolytic anaemia. Countries should be informed of the prevalence of this enzymatic anomaly within their borders, in order to make safe and appropriate national decisions regarding the use of potentially unsafe drugs for G6PD deficient individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A school-based cross-sectional survey was conducted in three districts in Mozambique, namely Manhi\u00e7a, located in the south; Mocuba in the centre; and Pemba in the northern tip of the country. G6PD deficiency was evaluated using the CareStart\u2122 diagnostic test, and enzyme activity levels were measured through fluorescence spectrophotometry in deficient individuals. Chi squared and ANOVA tests were used to assess prevalence and mean enzyme activity differences, and logistic regression was used to identify risk factors associated to the deficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>G6PD deficiency prevalence estimates were lowest in the northern city of Pemba (8.3%) and among Emakhuwas and Shimakondes, and higher in the centre and southern regions of the country (16.8 and 14.6%, respectively), particularly among Elomwes and Xichanganas. G6PD deficiency was significantly more prevalent among male students than females (OR\u00a0=\u00a01.4, 95% CI 1.0\u20131.8, p\u00a0=\u00a00.02), although enzyme activity levels were not different among deficient individuals from either gender group. Finally, median deficiency levels were found to be more severe among the deficient students from the north (0.7\u00a0U\/gHg [0.2\u20130.7] p\u00a0&lt;\u00a00.001) and south (0.7\u00a0U\/gHg [0.5\u20132.5]), compared to those from the centre (1.4\u00a0U\/gHg [0.6\u20132.1]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings suggest that Mozambique, as a historically high malaria-endemic country has considerable levels of G6PD deficiency, that vary significantly across the country. This should be considered when planning national strategies for the use of licensed drugs that may be associated to haemolysis among G6PD individuals, or prior to the performance of future trials using primaquine and other 8-aminoquinolines derivatives.<\/jats:p>\n                <jats:p><jats:italic>Registration Number<\/jats:italic> CISM local ethics committee (CIBS-25\/013, 4th of December 2013), and the National Ethics Committee of Mozambique (IRB00002657, 28th of February 2014).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-016-1674-y","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T14:10:18Z","timestamp":1484835018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-6385","authenticated-orcid":false,"given":"Beatriz","family":"Galatas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Mabote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Matambisso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Nhamussua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Mar","family":"Ma\u00f1\u00fa-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Saute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eusebio","family":"Macete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"1674_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"1674_CR2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood.V54.5.961.961","volume":"54","author":"L Luzzatto","year":"1979","unstructured":"Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood. 1979;54:961\u201376.","journal-title":"Blood"},{"key":"1674_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3855\/jidc.1837","volume":"5","author":"AE Orimadegun","year":"2011","unstructured":"Orimadegun AE, Sodeinde O. Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children. J Infect Dev Ctries. 2011;5:792\u20138.","journal-title":"J Infect Dev Ctries"},{"key":"1674_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1073\/pnas.80.1.298","volume":"80","author":"EF Roth","year":"1983","unstructured":"Roth EF, Raventos-Suarez C, Rinaldi A, Nagel RL. Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc Natl Acad Sci USA. 1983;80:298\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1674_CR5","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1371\/journal.pmed.0040066","volume":"4","author":"A Guindo","year":"2007","unstructured":"Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007;4:e66.","journal-title":"PLoS Med"},{"key":"1674_CR6","doi-asserted-by":"publisher","first-page":"e1004960","DOI":"10.1371\/journal.pgen.1004960","volume":"11","author":"A Manjurano","year":"2015","unstructured":"Manjurano A, Sepulveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, et al. African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet. 2015;11:e1004960.","journal-title":"PLoS Genet"},{"key":"1674_CR7","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1016\/S2352-3026(15)00191-X","volume":"2","author":"L Luzzatto","year":"2015","unstructured":"Luzzatto L. G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria. Lancet Haematol. 2015;2:e400\u20131.","journal-title":"Lancet Haematol"},{"key":"1674_CR8","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","journal-title":"PLoS Med"},{"key":"1674_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u201378.","journal-title":"Blood Cells Mol Dis"},{"key":"1674_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0268-960X(96)90019-3","volume":"10","author":"E Beutler","year":"1996","unstructured":"Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev. 1996;10:45\u201352.","journal-title":"Blood Rev"},{"key":"1674_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-11-139","volume":"11","author":"C Van Malderen","year":"2012","unstructured":"Van Malderen C, Van Geertruyden J-P, Machevo S, Gonz\u00e1lez R, Bassat Q, Talisuna A, et al. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil\u2013dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012;11:139.","journal-title":"Malar J"},{"key":"1674_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00431-009-0952-x","volume":"168","author":"M Schuurman","year":"2009","unstructured":"Schuurman M, van Waardenburg D, Costa JD, Niemarkt H, Leroy P. Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency\u2014case report and literature review. Eur J Pediatr. 2009;168:779\u201382.","journal-title":"Eur J Pediatr"},{"key":"1674_CR13","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","volume":"84","author":"E Beutler","year":"1994","unstructured":"Beutler E. G6PD deficiency. Blood. 1994;84:3613.","journal-title":"Blood"},{"key":"1674_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency. Adv Parasitol. 2013;81:133\u2013201.","journal-title":"Adv Parasitol"},{"key":"1674_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/511881","volume":"44","author":"HA Torres","year":"2007","unstructured":"Torres HA, Barnett BJ, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis. 2007;44:887\u20138.","journal-title":"Clin Infect Dis"},{"key":"1674_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-1557(199703)6:2<89::AID-PDS261>3.0.CO;2-8","volume":"6","author":"TYK Chan","year":"1997","unstructured":"Chan TYK. Co-trimoxazole-induced severe hemolysis: the experience of a large general hospital in Hong Kong. Pharmacoepidemiol Drug Saf. 1997;6:89\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1674_CR17","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"1674_CR18","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1086\/324081","volume":"33","author":"J Horton","year":"2001","unstructured":"Horton J, Brueckner R. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis. Clin Infect Dis. 2001;33:1968\u201374.","journal-title":"Clin Infect Dis"},{"key":"1674_CR19","first-page":"183","volume":"38","author":"F Nieuwenhuis","year":"1986","unstructured":"Nieuwenhuis F, Wolf B, Bomba A, De Graaf P. Haematological study in Cabo Delgado province, Mozambique; sickle cell trait and G6PD deficiency. Trop Geogr Med. 1986;38:183\u20137.","journal-title":"Trop Geogr Med"},{"key":"1674_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/bjh.12716","volume":"164","author":"R Aguilar","year":"2014","unstructured":"Aguilar R, Moraleda C, Achtman AH, Mayor A, Quint\u00f3 L, Cister\u00f3 P, et al. Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum. Br J Haematol. 2014;164:877\u201387.","journal-title":"Br J Haematol"},{"key":"1674_CR21","first-page":"203","volume":"22","author":"L Reys","year":"1970","unstructured":"Reys L, Manso C, Stamatoyannopoulos G. Genetic studies on southeastern Bantu of Mozambique. I. Variants of glucose-6-phosphate dehydrogenase. Am J Hum Genet. 1970;22:203.","journal-title":"Am J Hum Genet"},{"key":"1674_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4269\/ajtmh.2010.09-0416","volume":"82","author":"KE Tinley","year":"2010","unstructured":"Tinley KE, Loughlin AM, Jepson A, Barnett ED. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2010;82:210\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"1674_CR23","doi-asserted-by":"publisher","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","volume":"6","author":"S Kim","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart\u2122 G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE. 2011;6:e28357.","journal-title":"PLoS ONE"},{"key":"1674_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-12-418","volume":"12","author":"RE Howes","year":"2013","unstructured":"Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J. 2013;12:418.","journal-title":"Malar J"},{"key":"1674_CR25","unstructured":"National Malaria Control Programme. National malaria indicator survey, Mozambique (MIS-2007). Ministry of Health."},{"key":"1674_CR26","unstructured":"Ministerio da Sa\u00fade (MISAU), Instituto Nacional de Estad\u00edstica (INE), ICF Internacional. Mo\u00e7ambique Inquerito Demogr\u00e1fico e de Sa\u00fade 2011. Calverton: MISAU, INE, ICFI."},{"key":"1674_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1365-3156.1999.00395.x","volume":"4","author":"IS Tantular","year":"1999","unstructured":"Tantular IS, Iwai K, Lin K, Basuki S, Horie T, Htay HH, et al. Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria. Trop Med Int Health. 1999;4:245\u201350.","journal-title":"Trop Med Int Health"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-016-1674-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:08:32Z","timestamp":1628611712000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1674-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1674-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]},"assertion":[{"value":"17 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"36"}}